Alpelisib plus fulvestrant for PIK3CA-mutated, hormone receptor-positive, human epidermal growth factor receptor-2–negative advanced breast cancer: final overall survival results from SOLAR-1
Titel:
Alpelisib plus fulvestrant for PIK3CA-mutated, hormone receptor-positive, human epidermal growth factor receptor-2–negative advanced breast cancer: final overall survival results from SOLAR-1
Auteur:
André, F. Ciruelos, E.M. Juric, D. Loibl, S. Campone, M. Mayer, I.A. Rubovszky, G. Yamashita, T. Kaufman, B. Lu, Y.-S. Inoue, K. Pápai, Z. Takahashi, M. Ghaznawi, F. Mills, D. Kaper, M. Miller, M. Conte, P.F. Iwata, H. Rugo, H.S.